Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
Arzneimittel-Forschung|September 5, 2009
Mean residence time as estimated from cropped and truncated momentsFrieder Keller, Bertram Hartmann, David CzockTherapeutic Drug Monitoring|November 3, 2009
Explicit solution of integrated 1 - exp equation for predicting accumulation and decline of concentrations for drugs obeying nonlinear saturation kineticsFrieder Keller, Bertram Hartmann, David CzockDeutsches Arzteblatt International|October 21, 2010
Drug therapy in patients with chronic renal failureBertram Hartmann, David Czock, Frieder KellerEuropean Journal of Drug Metabolism and Pharmacokinetics|December 20, 2013
Time of effect duration and administration interval for sitagliptin in patients with kidney failureFrieder Keller, Bertram Hartmann, David CzockClinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Review on pharmacokinetics and pharmacodynamics and the aging kidneyChristian Aymanns, Frieder Keller, Sebastian Maus, et al.Annals of Transplantation|January 1, 2013
Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantationFrieder Keller, Susanne Wiesner, Donald Bunjes, et al.Clinical Biochemistry|July 4, 2016
Performance of a phosphoflow assay to determine phosphorylation of S6 ribosomal protein as a pharmacodynamic read out for mTOR inhibitionEmaad Abdel-Kahaar, Mariana Kabakchiev, Bertram Hartmann, et al.European Journal of Internal Medicine|February 24, 2006
Malacoplakia in a renal transplant recipientThomas Pusl, Max Weiss, Bertram Hartmann, et al.Therapeutic Drug Monitoring|March 19, 2013
Development of a sensitive phospho-p70 S6 kinase ELISA to quantify mTOR proliferation signal inhibitionBertram Hartmann, Xuemei He, Frieder Keller, et al.Wiener Klinische Wochenschrift|August 5, 2010
[Questionnaire surveying nephrologists on drug dose adjustment in patients with impaired kidney function]Sebastian Maus, Caecilia Holch, David Czock, et al.Pageof 2